No indications for altered essential fatty acid metabolism in two murine models for cystic fibrosis

A deficiency of essential fatty acids (EFA) is frequently described in cystic fibrosis (CF), but whether this is a primary consequence of altered EFA metabolism or a secondary phenomenon is unclear. It was suggested that defective long-chain polyunsaturated fatty acid (LCPUFA) synthesis contributes...

Full description

Bibliographic Details
Main Authors: Anniek Werner, Marloes E.J. Bongers, Marcel J. Bijvelds, Hugo R. de Jonge, Henkjan J. Verkade
Format: Article
Language:English
Published: Elsevier 2004-12-01
Series:Journal of Lipid Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520341080
id doaj-6cc2d0b69c274934a754169451a2f107
record_format Article
spelling doaj-6cc2d0b69c274934a754169451a2f1072021-04-27T04:46:45ZengElsevierJournal of Lipid Research0022-22752004-12-01451222772286No indications for altered essential fatty acid metabolism in two murine models for cystic fibrosisAnniek Werner0Marloes E.J. Bongers1Marcel J. Bijvelds2Hugo R. de Jonge3Henkjan J. Verkade4Department of Pediatrics, Center for Liver, Digestive and Metabolic Diseases, Academic Hospital Groningen, The Netherlands; Department of Biochemistry, Erasmus Medical Center, Rotterdam, The NetherlandsDepartment of Pediatrics, Center for Liver, Digestive and Metabolic Diseases, Academic Hospital Groningen, The Netherlands; Department of Biochemistry, Erasmus Medical Center, Rotterdam, The NetherlandsDepartment of Pediatrics, Center for Liver, Digestive and Metabolic Diseases, Academic Hospital Groningen, The Netherlands; Department of Biochemistry, Erasmus Medical Center, Rotterdam, The NetherlandsDepartment of Pediatrics, Center for Liver, Digestive and Metabolic Diseases, Academic Hospital Groningen, The Netherlands; Department of Biochemistry, Erasmus Medical Center, Rotterdam, The NetherlandsDepartment of Pediatrics, Center for Liver, Digestive and Metabolic Diseases, Academic Hospital Groningen, The Netherlands; Department of Biochemistry, Erasmus Medical Center, Rotterdam, The NetherlandsA deficiency of essential fatty acids (EFA) is frequently described in cystic fibrosis (CF), but whether this is a primary consequence of altered EFA metabolism or a secondary phenomenon is unclear. It was suggested that defective long-chain polyunsaturated fatty acid (LCPUFA) synthesis contributes to the CF phenotype. To establish whether cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction affects LCPUFA synthesis, we quantified EFA metabolism in cftr−/−CAM and cftr+/+CAM mice. Effects of intestinal phenotype, diet, age, and genetic background on EFA status were evaluated in cftr−/−CAM mice, ΔF508/ΔF508 mice, and littermate controls. EFA metabolism was measured by 13C stable isotope methodology in vivo. EFA status was determined by gas chromatography in tissues of cftr−/−CAM mice, ΔF508/ΔF508 mice, littermate controls, and C57Bl/6 wild types fed chow or liquid diet. After enteral administration of [13C]EFA, arachidonic acid (AA) and docosahexaenoic acid (DHA) were equally 13C-enriched in cftr−/−CAM and cftr+/+CAM mice, indicating similar EFA elongation/desaturation rates. LA, ALA, AA, and DHA concentrations were equal in pancreas, lung, and jejunum of chow-fed cftr−/−CAM and ΔF508/ΔF508 mice and controls. LCPUFA levels were also equal in liquid diet-weaned cftr−/−CAM mice and littermate controls, but consistently higher than in age- and diet-matched C57Bl/6 wild types. We conclude that cftr−/−CAM mice adequately absorb and metabolize EFA, indicating that CFTR dysfunction does not impair LCPUFA synthesis.A membrane EFA imbalance is not inextricably linked to the CF genotype. EFA status in murine CF models is strongly determined by genetic background.http://www.sciencedirect.com/science/article/pii/S0022227520341080arachidonic acidcystic fibrosis transmembrane conductance regulatordocosahexaenoic acidessential fatty acid deficiencyα-linolenic acidlinoleic acid
collection DOAJ
language English
format Article
sources DOAJ
author Anniek Werner
Marloes E.J. Bongers
Marcel J. Bijvelds
Hugo R. de Jonge
Henkjan J. Verkade
spellingShingle Anniek Werner
Marloes E.J. Bongers
Marcel J. Bijvelds
Hugo R. de Jonge
Henkjan J. Verkade
No indications for altered essential fatty acid metabolism in two murine models for cystic fibrosis
Journal of Lipid Research
arachidonic acid
cystic fibrosis transmembrane conductance regulator
docosahexaenoic acid
essential fatty acid deficiency
α-linolenic acid
linoleic acid
author_facet Anniek Werner
Marloes E.J. Bongers
Marcel J. Bijvelds
Hugo R. de Jonge
Henkjan J. Verkade
author_sort Anniek Werner
title No indications for altered essential fatty acid metabolism in two murine models for cystic fibrosis
title_short No indications for altered essential fatty acid metabolism in two murine models for cystic fibrosis
title_full No indications for altered essential fatty acid metabolism in two murine models for cystic fibrosis
title_fullStr No indications for altered essential fatty acid metabolism in two murine models for cystic fibrosis
title_full_unstemmed No indications for altered essential fatty acid metabolism in two murine models for cystic fibrosis
title_sort no indications for altered essential fatty acid metabolism in two murine models for cystic fibrosis
publisher Elsevier
series Journal of Lipid Research
issn 0022-2275
publishDate 2004-12-01
description A deficiency of essential fatty acids (EFA) is frequently described in cystic fibrosis (CF), but whether this is a primary consequence of altered EFA metabolism or a secondary phenomenon is unclear. It was suggested that defective long-chain polyunsaturated fatty acid (LCPUFA) synthesis contributes to the CF phenotype. To establish whether cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction affects LCPUFA synthesis, we quantified EFA metabolism in cftr−/−CAM and cftr+/+CAM mice. Effects of intestinal phenotype, diet, age, and genetic background on EFA status were evaluated in cftr−/−CAM mice, ΔF508/ΔF508 mice, and littermate controls. EFA metabolism was measured by 13C stable isotope methodology in vivo. EFA status was determined by gas chromatography in tissues of cftr−/−CAM mice, ΔF508/ΔF508 mice, littermate controls, and C57Bl/6 wild types fed chow or liquid diet. After enteral administration of [13C]EFA, arachidonic acid (AA) and docosahexaenoic acid (DHA) were equally 13C-enriched in cftr−/−CAM and cftr+/+CAM mice, indicating similar EFA elongation/desaturation rates. LA, ALA, AA, and DHA concentrations were equal in pancreas, lung, and jejunum of chow-fed cftr−/−CAM and ΔF508/ΔF508 mice and controls. LCPUFA levels were also equal in liquid diet-weaned cftr−/−CAM mice and littermate controls, but consistently higher than in age- and diet-matched C57Bl/6 wild types. We conclude that cftr−/−CAM mice adequately absorb and metabolize EFA, indicating that CFTR dysfunction does not impair LCPUFA synthesis.A membrane EFA imbalance is not inextricably linked to the CF genotype. EFA status in murine CF models is strongly determined by genetic background.
topic arachidonic acid
cystic fibrosis transmembrane conductance regulator
docosahexaenoic acid
essential fatty acid deficiency
α-linolenic acid
linoleic acid
url http://www.sciencedirect.com/science/article/pii/S0022227520341080
work_keys_str_mv AT anniekwerner noindicationsforalteredessentialfattyacidmetabolismintwomurinemodelsforcysticfibrosis
AT marloesejbongers noindicationsforalteredessentialfattyacidmetabolismintwomurinemodelsforcysticfibrosis
AT marceljbijvelds noindicationsforalteredessentialfattyacidmetabolismintwomurinemodelsforcysticfibrosis
AT hugordejonge noindicationsforalteredessentialfattyacidmetabolismintwomurinemodelsforcysticfibrosis
AT henkjanjverkade noindicationsforalteredessentialfattyacidmetabolismintwomurinemodelsforcysticfibrosis
_version_ 1721506344831287296